Gujarat Themis Biosyn Limited (GUJTHEM.NS) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-93.5%

₹24.57

vs ₹379.55 price

Levered DCF

-₹86.62

After debt service

Piotroski score

—

Altman Z-score

—

Rating

D+

Overall 1 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
P/E	53.14×	60.71×	44.84×	45.76×	60.87×
P/B	8.62×	11.93×	0×	0×	0×
P/S	14.96×	19.66×	15.62×	17.91×	23.23×
EV / EBITDA	33.86×	41.76×	0×	0×	0×
Gross margin	46.4%	78.9%	75.5%	79.2%	81.7%
Operating margin	37.8%	42.6%	44.5%	49.0%	49.5%
Net margin	28.2%	32.3%	34.8%	39.1%	38.2%
Current ratio	1.12×	2.53×	0×	0×	0×
Debt / equity	0.56×	0.12×	0×	0×	0×
Interest coverage	21.23×	275.99×	530.16×	764.88×	77.2×
Dividend yield	0.3%	0.0%	0.3%	0.5%	0.4%
Payout ratio	15.6%	0.0%	11.7%	21.1%	23.3%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Return on equity	16.2%	19.6%	0.0%	0.0%	0.0%
Return on invested capital	10.3%	17.0%	0.0%	0.0%	0.0%
Return on assets	9.3%	16.2%	0.0%	0.0%	0.0%
Free cash flow yield	-5.2%	-0.8%	0.0%	0.0%	0.0%
Earnings yield	1.9%	1.6%	2.2%	2.2%	1.6%
Enterprise value	₹26.4B	₹29.8B	₹0	₹0	₹0
Net debt / EBITDA	2.04×	0.26×	0×	0×	0×
Cash conversion cycle (days)	47	-34	0	0	0